THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $121 | -14.8% | 14,069 | +2.5% | 0.00% | 0.0% |
Q2 2023 | $142 | -16.0% | 13,723 | -11.8% | 0.00% | 0.0% |
Q1 2023 | $169 | -99.8% | 15,565 | +35.1% | 0.00% | 0.0% |
Q1 2022 | $110,000 | -4.3% | 11,525 | +10.6% | 0.00% | 0.0% |
Q4 2021 | $115,000 | -50.6% | 10,423 | +8.6% | 0.00% | -50.0% |
Q1 2018 | $233,000 | -44.0% | 9,599 | -35.7% | 0.00% | -33.3% |
Q4 2017 | $416,000 | +274.8% | 14,931 | +205.5% | 0.00% | +200.0% |
Q2 2016 | $111,000 | +68.2% | 4,887 | +40.2% | 0.00% | – |
Q1 2016 | $66,000 | +73.7% | 3,486 | +51.3% | 0.00% | – |
Q4 2015 | $38,000 | +11.8% | 2,304 | -25.9% | 0.00% | – |
Q3 2015 | $34,000 | +183.3% | 3,108 | +229.2% | 0.00% | – |
Q2 2015 | $12,000 | -7.7% | 944 | +28.8% | 0.00% | – |
Q1 2015 | $13,000 | +18.2% | 733 | +0.5% | 0.00% | – |
Q4 2014 | $11,000 | -45.0% | 729 | -16.0% | 0.00% | – |
Q3 2014 | $20,000 | -28.6% | 868 | 0.0% | 0.00% | – |
Q2 2014 | $28,000 | – | 868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
King Wealth Management Group | 22,500 | $583,000 | 0.15% |
Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |